Prenatal exposure to methamphetamine presenting as neonatal cholestasis

Journal of Clinical Gastroenterology

Volumn 43, Issue 1, 2009, Pages 88-90

  Dahshan, Ahmed ^a  

^a University of Oklahoma Tulsa College of Medicine   (United States)

Author keywords

Methamphetamine; Neonatal cholestasis; Prenatal drug exposure

Indexed keywords

AMPICILLIN; BILIRUBIN; GENTAMICIN; HEPATITIS B VACCINE; METHAMPHETAMINE; PHENOBARBITAL; URSODEOXYCHOLIC ACID; VITAMIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLANGIOGRAPHY; CHOLESTASIS; CLINICAL FEATURE; FEMALE; HEPATOBILIARY SCINTISCANNING; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LABORATORY TEST; LIVER BIOPSY; LIVER TOXICITY; MECONIUM; NEWBORN DISEASE; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; URINALYSIS;

AMPHETAMINE-RELATED DISORDERS; CHOLESTASIS; FEMALE; HUMANS; INFANT, NEWBORN; METHAMPHETAMINE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL INJURIES;

EID: 67651149628     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31812f4f0f     Document Type: Article

References (22)

1. Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2004;39:115-128.
2. Balistreri WF, Bezerra JA. Whatever happened to "neonatal hepatitis"? Clin Liver Dis. 2006;10:27-53, v.
3. Andreu V, Mas A, Bruguera M, et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol. 1998;29:394-397. (Pubitemid 28396655)
4. Dykhuizen RS, Brunt PW, Atkinson P, et al. Ecstasy induced hepatitis mimicking viral hepatitis. Gut. 1995;36:939-941.
5. Fidler H, Dhillon A, Gertner D, et al. Chronic ecstasy (3,4- methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis. J Hepatol. 1996; 25:563-566.
6. Nunez O, Banares R, Barrio J, et al. Variability of the clinical expression of ecstasy-induced hepatotoxicity. Gastroenterol Hepatol. 2002;25:497-500. (Pubitemid 36342523)
7. Lange-Brock N, Berg T, Muller AR, et al. Acute liver failure following the use of ecstasy (MDMA). Z Gastroenterol. 2002; 40:581-586. (Pubitemid 35014313)
8. Centers for Disease Control and Prevention (CDC). Acute public health consequences of methamphetamine laboratories- 16 states, January 2000-June 2004. MMWR Morb Mortal Wkly Rep. 2005;54:356-359.
9. Lineberry TW, Bostwick JM. Methamphetamine abuse: a perfect storm of complications. Mayo Clin Proc. 2006;81:77-84.
10. Smith L, Yonekura ML, Wallace T, et al. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr. 2003;24: 17-23. (Pubitemid 36305477)
11. Chomchai C, Na Manorom N, Watanarungsan P, et al. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2004;35: 228-231. (Pubitemid 38860086)
12. Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118:1149-1156. (Pubitemid 46090058)
13. Koksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr. 1996;85:1501-1502. (Pubitemid 26411418)
14. Bernstein SR, Krieger P, Puppala BL, et al. Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization. J Pediatr. 1994;125:621-622. (Pubitemid 24318439)
15. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64:566-576. (Pubitemid 46718289)
16. Khakoo SI, Coles CJ, Armstrong JS, et al. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage. J Clin Gastroenterol. 1995;20:244-247.
17. Kamijo Y, Soma K, Nishida M, et al. Acute liver failure following intravenous methamphetamine. Vet Hum Toxicol. 2002; 44:216-217. (Pubitemid 34778794)
18. Aknine X. Ecstasy-induced toxic hepatitis. Presse Med. 2004; 33(18 suppl):18-20.
19. Roques V, Perney P, Beaufort P, et al. Acute hepatitis due to ecstasy. Presse Med. 1998;27:468-470.
20. Brncic N, Kraus I, Viskovic I, et al. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis. Med Sci Monit. 2006;12:CS107-CS109.
21. Frey B, Braegger CP, Ghelfi D. Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann Pharmacother. 2002;36:644-647. (Pubitemid 34270281)
22. Ghishan FK. Trimethoprim-sulfamethoxazole-induced intrahepatic cholestasis. Clin Pediatr (Phila). 1983;22:212-214.